Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

被引：3
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 202卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000000443
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [1] Re: Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (04): : 1226 - 1227
  • [2] Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Kappeler, Christian
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13): : 1235 - 1246
  • [3] Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Le Berre, Marie-Aude
    Petrenciuc, Oana
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : 1040 - 1049
  • [4] FDA Approves Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (09) : 498 - 498
  • [5] ARAMIS: Efficacy and Safety of Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (04) : 2 - 5
  • [6] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [7] Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer
    Appukkuttan, Sreevalsa
    Farej, Ryan
    Miles, LaStella
    Purser, Molly
    Wen, Lonnie
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (02): : 166 - 174
  • [8] Impact of Darolutamide on Local Symptoms in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 11 - 12
  • [9] ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC).
    Fizazi, Karim
    Shore, Neal D.
    Tammela, Teuvo
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris Y.
    Kuss, Iris
    Kappeler, Christian
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew Raymond
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] IMPACT OF DAROLUTAMIDE ON LOCAL SYMPTOMS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Shore, Neal
    Stenzl, Arnulf
    Pieczonka, Christopher
    Klaassen, Zachary
    Aronson, William
    Karsh, Lawrence
    Ryan, Charles
    Miskic, Marina
    Srinivasan, Shankar
    Mohamed, Ateesha
    Verholen, Frank
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E586 - E587
12345